Osteoarthritis Trial, Recruiting NCT06929871 Sponsor: University College, London Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06929871
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have painful knee osteoarthritis and need a first-time total knee replacement surgery
  • People whose surgeon agrees that a total knee replacement is the most suitable treatment for their condition
  • People who have been assessed by a surgeon and anaesthetist and are considered medically safe to have surgery
  • People who are over 18 years old at the time of surgery
  • People of any gender (male or female)
  • People who are able to understand the study, give their consent, and are willing to follow the post-surgery review schedule
  • People who are mobile enough after surgery to attend follow-up appointments and have X-rays taken

Who may not be able to join:

  • People whose condition is too complex for a standard first-time knee replacement — for example, if ligament damage means a more specialised implant is needed
  • People who have significant bone loss that would require bone grafting or bone-building procedures during surgery
  • People who are not considered medically safe to have surgery
  • People who need a repeat knee replacement after a previous knee replacement or a bone-correcting surgery on the same leg has failed
  • People who have a bone density scan result showing a T-score below -2.5, indicating significant bone thinning (confirm with trial site)
  • People who are unable to walk independently, or who have a neurological condition that affects how their muscles and bones work
  • People who are under 18 years old at the time of surgery
  • People who are unable or unwilling to sign the study's consent form
  • People who are unable to attend the required follow-up appointments
  • People who have previously had a fracture caused by a bone disease or condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fares S Haddad, MBBS MD (Res) MCh (Orth) FRCS, UCL Hospitals NHS Foundation Trust

Phone: +442034479403

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 September 2025
Est. completion
31 July 2031

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

The Forgotten Joint Score [FJS]

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov